Antiparkinsonian activity of new N-methyl-D-aspartate receptor ligands in the arecoline hyperkinesis test

Introduction. Parkinson’s disease (PD) is one of the most common neurodegenerative diseases in the population of older patients. Even though long-term combination therapy helps to cope with the main manifestations of PD. It inevitably leads to the appearance of  such side effects as drowsiness, hall...

Full description

Bibliographic Details
Main Authors: V. D. Dergachev, E. E. Yakovleva, M. A. Brusina, E. R. Bychkov, L. B. Piotrovskiy, P. D. Shabanov
Format: Article
Language:Russian
Published: Remedium Group LLC 2021-09-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/6377